Insider sale
DYNE THERAPEUTICS, INC.
$378.9K
19.26K shares
What this filing means
ATLAS VENTURE OPPORTUNITY FUND II, L.P. plans to sell 19.26K shares of DYNE THERAPEUTICS, INC. valued at approximately $378.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/23/2026ACC: 0001628280-26-026890
10% Owner
Since Dec 2022
19.26K
Shares to sell
$378.9K
Approx. market value
19.26K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
12/12/2022
19.26KTotal acquired19.26K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/12/2022 | Private Placement Cash | 19.26K | — |
| Total | 19.26K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
19.26K
Market value
$378.9K
4/23/2026
Total
Units
19.26K
Value
$378.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/23/2026 | 19.26K | $378.9K | Nasdaq | Planned |
| Total | 19.26K | $378.9K | ||